Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://graysonfszz782607.blog-a-story.com/20438623/retaglutide-a-promising-glp-1-receptor-agonist